A
Amylyx Pharmaceuticals (AMLX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Amylyx Pharmaceuticals (AMLX)
Amylyx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapies for treatment paradigm for amyotrophic lateral sclerosis (ALS), and range of neurodegenerative diseases by keeping neurons alive. The Comp... Read more
- USD14.73
- USD15.53
- USD14.17
- 1.41M
Stock News
yesterday
Stocks fall as S&P 500 dragged down by tech. Is the selling over?
MarketWatch
yesterday
AI disruption fears rock software stocks again. How Jim Cramer is navigating the sell-off
CNBC
yesterday
Nvidia, OpenAI appear stalled on their mega deal. But the AI giants still need each other
CNBC
yesterday
Private credit stocks plummet on concern about exposure to software industry disrupted by AI
CNBC